Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 22,341,564 $ 16,737,109
Other current assets 106,800 62,690
Total current assets 22,448,364 16,799,799
Other non-current assets 68,858 68,858
Total assets 22,517,222 16,868,657
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,239,937 1,176,666
Total current liabilities and total liabilities 1,239,937 1,176,666
Commitments and contingencies (Note 6) 0 0
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 12,590,612 and 11,453,465 shares issued and outstanding at September 30, 2021, and December 31, 2020, respectively 12,591 11,453
Additional paid-in capital 59,877,631 47,873,570
Accumulated other comprehensive loss (5,147) (7,873)
Accumulated deficit (38,607,790) (32,185,159)
Total stockholders' equity 21,277,285 15,691,991
Total liabilities and stockholders' equity $ 22,517,222 $ 16,868,657